In a novel blood-based test, the methylation status of septin9 showed a sensitivity of 68% and a specificity of 80% in diagnosing CRC, but this is not yet validated for systematic use worldwide [19]. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.